Scandinavia Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Scandinavia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Scandinavian pharmaceuticals market had total revenues of $17.1 billion in 2022, representing a compound annual growth rate (CAGR) of 3.4% between 2017 and 2022.
- 0
- Sweden acquired a 38% share of the Scandinavian pharmaceuticals market in 2022. The Nordics are a significant hub for pharmaceutical innovation and production, with Finland having one of Europe's fastest-aging populations. With over 23% of people aged 65 or over, the region has a high life expectancy at birth. Lifestyle-related diseases like diabetes and obesity are driving growth in the pharmaceutical markets, particularly cardiovascular ones.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Scandinavia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Scandinavia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavia pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Scandinavia pharmaceuticals market by value in 2022?
- What will be the size of the Scandinavia pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Scandinavia pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Scandinavia's pharmaceuticals market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the most recent market developments?
- 8 Company Profiles
- 8.1. Novartis AG
- 8.2. Sanofi SA
- 8.3. Pfizer Inc.
- 8.4. F. Hoffmann-La Roche Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Scandinavia pharmaceuticals market value: $ billion, 2017-22
- Table 2: Scandinavia pharmaceuticals market geography segmentation: $ billion, 2022
- Table 3: Scandinavia pharmaceuticals market value forecast: $ billion, 2022-27
- Table 4: Novartis AG: key facts
- Table 5: Novartis AG: Annual Financial Ratios
- Table 6: Novartis AG: Key Employees
- Table 7: Novartis AG: Key Employees Continued
- Table 8: Sanofi SA: key facts
- Table 9: Sanofi SA: Annual Financial Ratios
- Table 10: Sanofi SA: Key Employees
- Table 11: Sanofi SA: Key Employees Continued
- Table 12: Pfizer Inc.: key facts
- Table 13: Pfizer Inc.: Annual Financial Ratios
- Table 14: Pfizer Inc.: Key Employees
- Table 15: Pfizer Inc.: Key Employees Continued
- Table 16: F. Hoffmann-La Roche Ltd: key facts
- Table 17: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
- Table 18: F. Hoffmann-La Roche Ltd: Key Employees
- Table 19: Scandinavia exchange rate, 2018-22
- List of Figures
- Figure 1: Scandinavia pharmaceuticals market value: $ billion, 2017-22
- Figure 2: Scandinavia pharmaceuticals market geography segmentation: % share, by value, 2022
- Figure 3: Scandinavia pharmaceuticals market value forecast: $ billion, 2022-27
- Figure 4: Forces driving competition in the pharmaceuticals market in Scandinavia, 2022
- Figure 5: Drivers of buyer power in the pharmaceuticals market in Scandinavia, 2022
- Figure 6: Drivers of supplier power in the pharmaceuticals market in Scandinavia, 2022
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Scandinavia, 2022
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Scandinavia, 2022
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Scandinavia, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook